Reddit Posts
Mentions
NVNO looks like a reversal trade for next week, FDA set back sent a major sell off, but they have large cash reserves to keep them running, looking to buy some mid .3s
Taken some $NVNO for a swing based on its cash value, seems to have bottomed out
NVNO market cap is lower than it's cash position
Same thing for NVNO but look at them now, so maybe OP could make bank cause it seems getting fda approval is not as easy as it seems if you don’t have any strings to pull.
https://preview.redd.it/pycpoau6uklf1.jpeg?width=1290&format=pjpg&auto=webp&s=9106f5376c1d566b3ed86c9a715a4545f1ee4e7c $NVNO 🤩
$NVNO volume picked up well today👀
NVNO up 5% not much for penny, but green for the morning
NVNO new oral market for GLP-1s in obesity👆 Bull and Bear analysts https://www.morningstar.com/stocks/is-novo-nordisk-stock-buy-after-its-share-price-collapse
Where is the NVNO guy. He's been pumping that for weeks now. FDA letter today .... not good Bob
Hope no one bought into that person shamelessly plugging NVNO shit stock 👀
NVNO up 14% AH. Tried telling yall.
$NVNO and for many reasons: 1. Their device (VenoValve) is a Class III implantable valve for CVI, a disease where there are currently ZERO surgical treatments – only symptom management. 2. FDA PMA (Premarket Approval) process: 4/5 sections are already approved. The last one is clinical data. FDA APPROVAL IS ANY DAY/WEEK NOW 3. Clinical trial results? Strong – main knock is the small sample size (~75 pts), but that’s allowed under FDA’s Breakthrough Device Designation, since this condition is so underserved. 4. If approved, this would be the first surgical option ever for severe cases of CVI. That’s massive TAM. 5. Trump was recently diagnosed with this condition and news articles are drawing more attention to the condition (some as recent as the Alaska meeting with Putin), which is underdiagnosed cause a lot of people don’t know what CVI is
$NVNO and for many reasons: 1) Their device (VenoValve) is a Class III implantable valve for CVI, a disease where there are currently ZERO surgical treatments – only symptom management. 2) FDA PMA (Premarket Approval) process: 4/5 sections are already approved. The last one is clinical data. FDA APPROVAL IS ANY DAY/WEEK NOW 3) Clinical trial results? Strong – main knock is the small sample size (~75 pts), but that’s allowed under FDA’s Breakthrough Device Designation, since this condition is so underserved. 4) If approved, this would be the first surgical option ever for severe cases of CVI. That’s massive TAM. 5) Trump was recently diagnosed with this condition and news articles are drawing more attention to the condition, which is underdiagnosed cause a lot of people don’t know what CVI is
NVNO and for many reasons: 1) Their device (VenoValve) is a Class III implantable valve for CVI, a disease where there are currently ZERO surgical treatments – only symptom management. 2) FDA PMA (Premarket Approval) process: 4/5 sections are already approved. The last one is clinical data. 3) Clinical trial results? Strong – main knock is the small sample size (~75 pts), but that’s allowed under FDA’s Breakthrough Device Designation, since this condition is so underserved. 4) If approved, this would be the first surgical option ever for severe cases of CVI. That’s massive TAM. 5) Trump was recently diagnosed with this condition and news articles are drawing more attention to the condition, which is underdiagnosed cause a lot of people don’t know what CVI is
NVNO and for many reasons: 1) Their device (VenoValve) is a Class III implantable valve for CVI, a disease where there are currently ZERO surgical treatments – only symptom management. 2) FDA PMA (Premarket Approval) process: 4/5 sections are already approved. The last one is clinical data. 3) Clinical trial results? Strong – main knock is the small sample size (~75 pts), but that’s allowed under FDA’s Breakthrough Device Designation, since this condition is so underserved. 4) If approved, this would be the first surgical option ever for severe cases of CVI. That’s massive TAM. 5) Trump was recently diagnosed with this condition and news articles are drawing more attention to the condition, which is underdiagnosed cause a lot of people don’t know what CVI is
Buying and loading up shares of NVNO - days/weeks away from FDA approval for first in class treatment for Chronic Venous Insufficiency - condition that Trump was diagnosed with few weeks ago. Think we are about to see this thing go parabolic
Buying and loading up shares of NVNO - days/weeks away from FDA approval for first in class treatment for Chronic Venous Insufficiency - condition that Trump was diagnosed with few weeks ago. Think we are about to see this thing go parabolic
Buying and loading up shares of NVNO - days/weeks away from FDA approval for first in class treatment for Chronic Venous Insufficiency - condition that Trump was diagnosed with few weeks ago. Think we are about to see this thing go parabolic
NVNO is going to be a winner in the next couple weeks. FDA approval is on deck, 4 out of 5 PMA submission chapters already approved, clinical data (1 and 2 year post op) look great (final chapter need approval), FDA break through device designation, and will be the first implantable device that treats CVI - condition that Trump was diagnosed with weeks ago
NVNO is going to be a winner in the next couple weeks. FDA approval is on deck, 4 out of 5 PMA submission chapters already approved, clinical data (1 and 2 year post op look great), FDA break through device recognition, and will be the first implantable device that treats CVI - condition that Trump was diagnosed with weeks ago
NVNO sitting at sub 5$ weeks before FDA approval
$NVNO is the next big winner - FDA approval expected August (4 out of 5 PMA chapters already approved, last chapter is clinical data which was excellent), breakthrough device designation by the FDA, first surgical treatment for deep Chronic Venous Insufficiency (which is what Trump was diagnosed with couple weeks ago). 90 mill market cap with 40 mill cash on hand. It’s a no brainer and should easily be 300 mill market cap after approval.
Anyone hear of $NVNO before? They are in the late stage FDA approval cycle for their first in class Venovalve which treats deep Chronic Venous Insufficiency, which is what Trump was diagnosed with couple weeks ago. Seems like a good time to buy
$CLBR $SMX $CVNA $NVNO $FYBR https://preview.redd.it/zhbnon14qycb1.jpeg?width=576&format=pjpg&auto=webp&s=23f766ba486c6b7ae3946106e1fbba5cfb330ad4
NCNA, SLNO, NVNO, OBSV, ACHV, MBRX, NVCN all are waiting for some good news. I am waiting which will be first.